{
    "2019-09-10": [
        [
            {
                "time": "",
                "original_text": "白云山拟分拆医药流通子公司赴港股上市",
                "features": {
                    "keywords": [
                        "白云山",
                        "分拆",
                        "医药流通",
                        "港股",
                        "上市公司"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "白云山(00874)向兴证资管出售基础资产并拟发行30亿元资产支持证券 资产异常",
                "features": {
                    "keywords": [
                        "白云山",
                        "出售资产",
                        "兴证资管",
                        "资产支持证券",
                        "30亿元",
                        "资产异常"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "白云山(00874.HK)拟分拆广州医药到港交所上市及广州医药申请增加不超135亿元授信额度",
                "features": {
                    "keywords": [
                        "白云山",
                        "分拆",
                        "广州医药",
                        "港交所",
                        "上市",
                        "授信额度",
                        "135亿元"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "白云山(600332.SH)：医药公司拟开展资产证券化业务",
                "features": {
                    "keywords": [
                        "白云山",
                        "资产证券化",
                        "医药公司"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}